Core Viewpoint - Ying Tai Medical (01501.HK) has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H-shares, indicating a strategic move to enhance liquidity and market presence [1] Summary by Relevant Sections - Company Actions - The company has applied to convert a total of 71,786,608 shares of domestic shares held by certain shareholders into H-shares for listing on the Hong Kong Stock Exchange [1] - The conversion and listing will occur once all necessary approvals from regulatory bodies, including the CSRC and the Stock Exchange, are obtained [1] - Regulatory Compliance - The company is not required to hold a shareholders' meeting to approve the conversion and listing as per its articles of association [1]
瑛泰医疗(01501.HK)建议实施H股全流通